Ukuba awuyazi ngoku, intlungu kunye nokudandatheka kukuhlobene. Ngokutsho kwinqaku epapashwe kwi- Pharmacist yase-US ngo-2009, iimpawu zezi zimbini zimekeke. Eli nqaku libika ngedatha evela kwi-National Health and Nutrition Examination Survey III ekufumaneni ukuba ukuya kwi-10% yabantu abadandathelwanayo, apho i-90% ibika ingxelo.
Eli nqaku liqhubeka lisithi isiseko sebhaloji sokudandatheka singumdlali onokubangela ubunzima obungapheliyo. Ngenxa yalesi sizathu, izidakamizwa zino-anti-depressants zingenza uhlobo olusebenzayo lwamayeza onyango olungapheliyo okanye intlungu.
Enyanisweni, i-antidepressants ziye zabonakaliswa ngempumelelo kwiintlobo ezahlukeneyo zentlungu engapheliyo, kuquka intlungu yesibindi, intlungu yomzimba ehambisana nokudakumba, kunye ne-fibromyalgia, ngokubhekiselele kwinqaku. Ababhali bathi iindidi ezahlukeneyo zokuxhatshazwayo ziyasebenza kwiintlobo ezahlukeneyo zentlungu.
Iintlobo ze-tricyclic anti-depressants ezichazwe ngentlungu yesibindi ziquka i-amitriptyline, i-nortriptyline, i-desipramine, kunye ne-anti-depressants novel, i-venlafaxine kunye ne-duloxetine (igama lophawu lwegama elithi Cymbalta.)
Malunga neTricyclic Antidepressants
I-Tricyclic antidepressants yiklasi lemishishini evunywe yi-FDA yokunyangwa kwengxaki. Nangona i-FDA ingabamkeli njengonyango lwamazibuhlungu, oogqirha ngamanye amaxesha bayayibhalela ngokusetyenziswa kwalo nangoko. (Oku kuthiwa yi -label-off label .) Xa i-anti-depressants ithathwa ngenxa yeentlungu zentlungu, injenge - adjuvant , oko kukuthi, ukuya kwiprojekti ephambili yonyango
Ukuba uthatha i-tricyclic antidepressant ngenxa yentlungu, i-dose yakho iya kuba isezantsi kunokuba uyithatha ingcinezelo.
Imiphumela
Iithagethi ze-tricyclic antidepressants azikhawulelwanga kukudandatheka kunye nentlungu. Ezi zi yobisi zichaphazela inani lamalungu omzimba. Ngenxa yolu, uluhlu lweempembelelo luya kwenzeka.
Iziphumo ezinokuthi zikwazi ukulawulwa (umlomo owomileyo, ukutyikitya, ukulala) okanye ubunzima kakhulu (ukukhawuleza kwentliziyo, ukugqithisa kwe-glaucoma, ingozi eyingozi yokubamba, ukubiza ngambalwa.) Kubalulekile ukuba uxoxe ngokunyanisekileyo nodokotela wakho malunga nayiphi Ezinye iimeko onokuba nazo ukuze ukwazi ukuchaneka ukuba olu hlobo lonyango lwenyango lufanelekile.
Njengoko kuchazwe ngentla, ezinye zeengxelo zokudambisa iingxaki zisebenza ngokufanelekileyo ekulawuleni ubuhlungu be-back neuropathic . Iindaba ezilungileyo kukuba zingaphinde zibe nemiphumo emibini engaphantsi kwezinye iintlobo ze-tricyclic anti-depressants. Ngaphazamisekanga, ezinye iincwadi ezinomdla wokuxhatshazwa kakhulu zijoliswe kakhulu ekusebenzisaneni kwamakhemikhali okubhekiselele ekudakaleni, ukuba ngaphandle kokuba intlungu ibangelwa yinkinga yengqondo yengqondo, la mayeza angeke aphumelele ekukhuliseni.
Kwakhona kuthiwa ngamachiza okulwa ne-anti-seizure, nezinye iindidi zeentlungu ezixhamlayo ezisetyenziselwa ukunyanga iintlungu ezingapheliyo zizo zikho kwiklasi ye-anticonvulsant. Amachiza okulwa neengxaki zokubamba ubuhlungu obungapheliyo asebenzayo kunye kunye nokuxhatshazwa kweengxaki kodwa ziza nezikhuseliso ezahlukeneyo kunye neziphumo zecala . Olu hlobo lwesilwanyana lungenza ukhetho olungcono kubadala kunye nabalupheleyo kuba iingxaki zokukhuseleka zimbalwa kunezidandlululo.
Imithombo:
Maizels, Morris, MD, & McCarberg, uBill, MD (2005). Izidakamizwa kunye ne-Antiepileptic Drugs for Pain Non-Cancer Pain. I-American Family Physician, 71. http://www.aafp.org/afp/20050201/483.html
UGould, uHarry J., III, MD. Ukuqonda Intlungu: Yintoni eyenza ukuba kwenzeke, kwaye ilawulwa njani. ENew York: Iimfuno, 2007. Print
Fink, K., MD, uMlawuli weeNkonzo zoPhando. Isibhedlele Sokubuyiselwa KweSizwe, eWashington, DC. Ngomnxeba. Matshi 9, 2009.
U-Moultry, A., PharmD, MS; I-Poon, I. I-PharmD, i-BCPS, i-CGP. Ukusetyenziswa kwee-Antidepressants for Pain Pain. Um Pharmist waseMelika. 2009.Iziko leMedscape. http://www.medscape.com/viewarticle/704975